Gene therapy for hemophilia represents a groundbreaking advancement in treating this challenging bleeding disorder, offering hope for those who have long faced the burden of constant worry and daily injections.Recently, the FDA's approval of Hemgenix has spurred a new wave of optimism, particularly among patients and families seeking effective hemophilia B treatment.